Cell-Free DNA (cfDNA) Testing Market
Cell-Free DNA (cf-DNA) Testing Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Cell-Free DNA (cf-DNA) Testing Market Size and Growth
The Cell-Free DNA (cf-DNA) testing market is rapidly expanding, driven by advancements in non-invasive prenatal testing and oncology applications. Valued at approximately $2 billion, the market is projected to grow significantly, fueled by increasing demand for personalized medicine and early disease detection, alongside technological innovations in genetic testing. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Agilent Technology
◍ Allenex
◍ Biocept
◍ Biodesix
◍ CareDx
◍ Guardant Health
◍ Illumania
◍ Invited
◍ Natera
◍ Quest Diagnostics
◍ Roche
◍ Sequenom
◍ Trovagene
The cell-free DNA (cf-DNA) testing market features players like Guardant Health and Natera, which innovate in oncology testing. Companies like Quest Diagnostics and Roche enhance testing accessibility, while Biocept and CareDx offer transplantation solutions. These collaborations and innovations drive market growth.
**Sales Revenue Figures:**
- Guardant Health: $220 million (2022)
- Natera: $320 million (2022)
- Quest Diagnostics: $3.6 billion (2022)
Request Sample Report
